Effectiveness of Guanxinning Tablet on the Stable Coronary Artery Disease based on the Real World: A Multi-center Registration Study
Phase 4
- Conditions
- stable Coronary Heart Disease
- Registration Number
- ITMCTR1900025340
- Lead Sponsor
- Xiyuan Hospital, CACMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Patients with stable coronary artery disease with definitive diagnosis
(2) Voluntary participation in this research
Exclusion Criteria
Other conditions considered unsuitable for participation in this research by the researchers.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major Adverse Cardiovascular and Cerebrovascular Events (All-cause death, cardiovascular death, non-fatal myocardial infarction, stent thrombosis, target lesion revascularization and cerebral arterial thrombosis);
- Secondary Outcome Measures
Name Time Method TCM main symptom score;cardiac insufficiency;arrhythmia;Re-hospitalization for unstable angina;Seattle Angina Questionnaire;